Help - Search - Members - Calendar
Full Version: Arthritis
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Internal Medicine Forum > Medicine Topics > Arthritis
Pages: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
  1. Arthritis: Variable responses of formyl peptide receptor haplotypes toward bacterial peptides (0 replies)
  2. Arthritis: Serum igg activity against cyclic citrullinated peptide in patients evaluated for rheumatoid factor correlates with the igm isotype (0 replies)
  3. Arthritis: Etanercept-methotrexate better than monotherapy for ra (0 replies)
  4. Arthritis: Inflammation linked to oxidized lp(a) increases (0 replies)
  5. Arthritis: Rupture of renal artery aneurysm due to salmonella infection in a patient with systemic lupus erythematosus. (0 replies)
  6. Arthritis: Do children with lupus have fewer male siblings? (0 replies)
  7. Arthritis: A/c polymorphism in the interleukin-18 coding region among taiwanese systemic lupus erythematosus patients. (0 replies)
  8. Arthritis: Safety fears allayed over therapy-induced lymphopenia (0 replies)
  9. Arthritis: Meniscal damage and the development of persistent knee pain (0 replies)
  10. Arthritis: Ra therapies 'less effective in late-stage disease' (0 replies)
  11. Arthritis: Use of multiple nsaids reduces arthritis pain but may increase complications (0 replies)
  12. Arthritis: Rheumatoid arthritis causes retirement (0 replies)
  13. Arthritis: What do we know about communicating risk? a brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective nsaids (0 replies)
  14. Arthritis: Health tip: am i getting too old to drive? (0 replies)
  15. Arthritis: Fda oks first generic fosamax (0 replies)
  16. Arthritis: Fda agrees to review cimzia(r) file for the treatment of rheumatoid arthritis (0 replies)
  17. Arthritis: Long-term improvement seen with hip replacement (0 replies)
  18. Arthritis: Histological analysis of synovium in cases of effect attenuation associated with infliximab therapy in rheumatoid arthritis (0 replies)
  19. Arthritis: Therapeutic effect of kalpaamruthaa, a herbal preparation on adjuvant induced arthritis in wistar rats (0 replies)
  20. Arthritis: Genetic role in psoriasis skin disease confirmed (0 replies)
  21. Arthritis: Common interleukin 6 promoter variants associate with the more severe forms of distal interphalangeal osteoarthritis (0 replies)
  22. Arthritis: Merck to pay $650 million in medicaid settlement (0 replies)
  23. Arthritis: Merck will pay $671m to settle claims that it overcharged medicaid for prescription drugs, bribed physicians (0 replies)
  24. Arthritis: The specificity of jak3 kinase inhibitors (0 replies)
  25. Arthritis: Gene linked to inflammatory arthritis also raises heart risks (0 replies)
  26. Arthritis: Gene linked to inflammatory arthritis also raises heart risks (0 replies)
  27. Arthritis: Gene linked to inflammatory arthritis also raises heart risks (0 replies)
  28. Arthritis: United states: drug warning claims 'impliedly preempted' but asks high court to hold off (0 replies)
  29. Arthritis: Merck posts loss on charges to settle pending vioxx litigation (0 replies)
  30. Arthritis: Florida vioxx users claim settlement has left them empty handed (0 replies)
  31. Arthritis: Gene linked to increased risk of developing inflammatory arthritis may also increase patients' risk of dying from cardiovascular disease (0 replies)
  32. Arthritis: The problem of detecting and managing depression in the rheumatology clinic (0 replies)
  33. Arthritis: Blame sweet soda for gout? (0 replies)
  34. Arthritis: Infection in primary total knee replacement. (0 replies)
  35. Arthritis: Incidence and characteristics of arthritis in norwegian children: a population-based study (0 replies)
  36. Arthritis: Neurofit (0 replies)
  37. Arthritis: Taking more than one anti-inflammatory drug may lead to complications (0 replies)
  38. Arthritis: Supreme court to hear drug preemption arguments at feb. 25 session (0 replies)
  39. Arthritis: New jersey attorney general opens probe into amgen's marketing of enbrel (0 replies)
  40. Arthritis: Critic says settlement requires attorneys to violate duty to clients (0 replies)
  41. Arthritis: Judge names masters to serve in settlement (0 replies)
  42. Arthritis: Former vioxx users say national settlement extinguishes their claims (0 replies)
  43. Arthritis: Lawyers say settlement's restrictions on practice violate ethical rules (0 replies)
  44. Arthritis: Objections evaporate; 1 case dismissed, another withdrawn (0 replies)
  45. Arthritis: How poxviruses such as smallpox evade the immune system (0 replies)
  46. Arthritis: Pathway to turn off immune system cells discovered (0 replies)
  47. Arthritis: Identifying patients at high risk for total hip replacement (0 replies)
  48. Arthritis: A pathway discovered to turn off immune system cells (0 replies)
  49. Arthritis: Rheumatic complaints not just a problem for the western world (0 replies)
  50. Arthritis: Signal transduction of inflammatory synoviocytes in rheumatoid arthritis. (0 replies)
  51. Arthritis: Can serum procalcitonin help to differentiate between septic and nonseptic arthritis? (0 replies)
  52. Arthritis: Spinal subdural haematoma: a rare complication of low-molecular-weight heparin therapy. (0 replies)
  53. Arthritis: Chronic posttraumatic elbow disorders treated with metallic radial head arthroplasty (0 replies)
  54. Arthritis: Co-expression of il-18 binding protein and il-4 regulates th1/th2 cytokine response in murine collagen-induced arthritis. (0 replies)
  55. Arthritis: [original articles] factors associated with hip protector adherence among older people in residential care (0 replies)
  56. Arthritis: The widening mortality gap between people with rheumatoid (0 replies)
  57. Arthritis: Arthritis & rheumatism ± 50 (0 replies)
  58. Arthritis: Evaluation of cartilage and bone degradation in a murine collagen antibody-induced arthritis model (0 replies)
  59. Arthritis: Absence of in vitro responses to type ii collagen by splenocytes from arthritic balb/c mice is possibly caused by intrinsic cd25+ regulatory cells (0 replies)
  60. Arthritis: Benefit-finding among people with rheumatoid arthritis in japan (0 replies)
  61. Arthritis: An inverse association between self-reported arthritis and mortality in the elderly: findings from the national long term care survey (0 replies)
  62. Arthritis: Picomm-issue 37 (0 replies)
  63. Arthritis: New jersey judge finds filing procedures open to defendant abuse (0 replies)
  64. Arthritis: Plaintiffs say pfizer not entitled to documents it seeks (0 replies)
  65. Arthritis: New york justice says 200-milligram celebrex data don't meet frye-parkertest (0 replies)
  66. Arthritis: Chelsea therapeutics launches drug trial (0 replies)
  67. Arthritis: Is there a role for omega 3 supplements in inflammatory arthritis? (0 replies)
  68. Arthritis: Arthritic knees remain painful after arthroscopic surgery (0 replies)
  69. Arthritis: Arthritis foundation announces top 10 arthritis advances of 2007 (0 replies)
  70. Arthritis: Synoviocyte stimulation by the lfa-1-intercellular adhesion molecule-2-ezrin-akt pathway in rheumatoid arthritis. (0 replies)
  71. Arthritis: Successful treatment of animal models of rheumatoid arthritis with small-molecule cyclin-dependent kinase inhibitors. (0 replies)
  72. Arthritis: The soluble leukocyte-associated ig-like receptor (lair)-2 antagonizes the collagen/lair-1 inhibitory immune interaction. (0 replies)
  73. Arthritis: Autoantigen-specific il-10-transduced t cells suppress chronic arthritis by promoting the endogenous regulatory il-10 response. (0 replies)
  74. Arthritis: Distinct in vivo roles of cd80 and cd86 in the effector t-cell responses inducing antigen-induced arthritis (0 replies)
  75. Arthritis: Early lymphocyte activation in the synovial microenvironment in patients with osteoarthritis: comparison with rheumatoid arthritis patients and healthy controls (0 replies)
  76. Arthritis: Anaesthesiological problems in patients with rheumatoid arthritis undergoing orthopaedic surgeries (0 replies)
  77. Arthritis: Correction: ultrasonography, magnetic resonance imaging, radiography, and clinical assessment of inflammatory and destructive changes in fingers and toes of patients with psoriatic arthritis (0 replies)
  78. Arthritis: Three-dimensional and thermal surface imaging produces reliable measures of joint shape and temperature: a potential tool for quantifying arthritis (0 replies)
  79. Arthritis: The role of tumor necrosis factor-alpha in systemic lupus erythematosus (0 replies)
  80. Arthritis: [arthritis due to listeria monocytogenes.] (0 replies)
  81. Arthritis: [expression analyses for rheumatoid arthritis.] (0 replies)
  82. Arthritis: Project will map genomes of 1,000 people worldwide (0 replies)
  83. Arthritis: Esophagus - upper gi endoscopic findings in scleroderma (0 replies)
  84. Arthritis: Human ra research bears out murine link between tnf blockade and b cells (0 replies)
  85. Arthritis: A new view of drugs used to treat rheumatoid arthritis (0 replies)
  86. Arthritis: New view of drugs used to treat rheumatoid arthritis (0 replies)
  87. Arthritis: Drugs used to treat rheumatoid arthritis may have hidden benefits (0 replies)
  88. Arthritis: Pro-inflammatory cytokine-induced sapk/mapk and jak/stat in rheumatoid arthritis and the new anti-depression drugs (0 replies)
  89. Arthritis: Induction of experimental arthritis in balb/c mice by inclusion of a foreign protein in the collagen inoculum (0 replies)
  90. Arthritis: Ra patients at increased risk for shingles (0 replies)
  91. Arthritis: The impact of substance p signalling on the development of experimental staphylococcal sepsis and arthritis (0 replies)
  92. Arthritis: Emerging viral infections and arthritis: the role of the rheumatologist (0 replies)
  93. Arthritis: Arterial elasticity: asset or liability? (0 replies)
  94. Arthritis: New insights in systemic juvenile idiopathic arthritis--from pathophysiology to treatment (0 replies)
  95. Arthritis: Auto-antibodies, hla and ptpn22: susceptibility markers for rheumatoid arthritis (0 replies)
  96. Arthritis: Association of autoantibodies with ku and dna repair proteins in connective tissue diseases (0 replies)
  97. Arthritis: Discrepancies between the eular response criteria and the nice guidelines for continuation of anti-tnf therapy in ra: a cause for concern? (0 replies)
  98. Arthritis: Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patient's perspective (0 replies)
  99. Arthritis: Evaluating the adequacy of disease control in patients with rheumatoid arthritis: a rand appropriateness panel (0 replies)
  100. Arthritis: Arthritis risk after acute bacterial gastroenteritis (0 replies)
  101. Arthritis: Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with tnf-{alpha} blocking drugs using a novel flow-cytometric interferon-{gamma} release assay (0 replies)
  102. Arthritis: Use of parenteral methotrexate significantly reduces the need for biological therapy (0 replies)
  103. Arthritis: Infliximab therapy reduces periodontoid rheumatoid pannus formation (0 replies)
  104. Arthritis: An unusual cause of abnormal liver function in a patient with rheumatoid arthritis (0 replies)
  105. Arthritis: Complete heart block after infliximab therapy (0 replies)
  106. Arthritis: Pneumococcal septic arthritis as the initial presentation of multiple myeloma. (0 replies)
  107. Arthritis: Arthritis drug etanercept clears up symptoms of psoriasis (0 replies)
  108. Arthritis: Untreated blood disorder leads to liver cancer and arthritis (0 replies)
  109. Arthritis: A new view of drugs used to treat rheumatoid arthritis (0 replies)
  110. Arthritis: Borrelia burgdorferi basic membrane proteins a and b participate in the genesis of lyme arthritis (0 replies)
  111. Arthritis: Correspondence: pansclerotic morphea of the head (0 replies)
  112. Arthritis: Triamcinolone: infectious arthritis and aspergillosis following intra-articular administration in an elderly patient: case report (0 replies)
  113. Arthritis: Modified-release prednisone reduces morning stiffness in patients with rheumatoid arthritis (capra-1 trial) (0 replies)
  114. Arthritis: In a women with several years persistent diarrhoea, is a raised iga significant? (0 replies)
  115. Arthritis: Entelos inks arthritis research deal with ucb pharma (0 replies)
  116. Arthritis: Entelos, ucb in arthritis research deal (0 replies)
  117. Arthritis: How anti-tnf compounds work (0 replies)
  118. Arthritis: The mmp2 rs243865-t allele is not a major genetic factor for rheumatoid arthritis in the french caucasian population (0 replies)
  119. Arthritis: Rheumatoid arthritis raises risk for shingles (0 replies)
  120. Arthritis: Modified-release prednisone may ease rheumatoid arthritis (0 replies)
  121. Arthritis: Modified-release prednisone may ease rheumatoid arthritis (0 replies)
  122. Arthritis: Modified-release prednisone may ease rheumatoid arthritis (0 replies)
  123. Arthritis: Etanercept for psoriasis in children and adolescents (0 replies)
  124. Arthritis: Modified-release prednisone reduces morning stiffness in patients
    with rheumatoid arthritis (capra-1 trial)     (0 replies)
  125. Arthritis: Delayed-release prednisone works for morning stiffness in ra (0 replies)
  126. Arthritis: Economic burden of psoriatic arthritis (0 replies)
  127. Arthritis: Economic burden of psoriatic arthritis. (0 replies)
  128. Arthritis: Triamcinolone: infectious arthritis and aspergillosis following intra-articular administration in an elderly patient: case report. (0 replies)
  129. Arthritis: U.s. food safety: foodborne illnesses a menu for disaster (0 replies)
  130. Arthritis: Stimulation of tlr2 and tlr4 differentially skews the balance of t cells in a mouse model of arthritis (0 replies)
  131. Arthritis: 'instant' alzheimer's drug claim (0 replies)
  132. Arthritis: Vgx pharmaceuticals receives fda clearance to commence clinical trials of vgx-1027, a novel oral drug with potent anti-inflammatory activity (0 replies)
  133. Arthritis: What guidance is there for stopping a patient's anti-tnf medications for rheumatoid arthritis when being treated with oral antibiotics? (0 replies)
  134. Arthritis: Persistence of weekly alendronate: a real-world study in croatia (0 replies)
  135. Arthritis: Gold nanoparticles shine brightly in tumors (0 replies)
  136. Arthritis: Septic arthritis of the shoulder: analysis of 19 cases (0 replies)
  137. Arthritis: How effective is a saline arthrogram for wounds around the knee? (0 replies)
  138. Arthritis: Alumina-on-alumina hip arthroplasty in patients younger than 30 years old. (0 replies)
  139. Arthritis: Acute pyogenic arthritis of the hip: an operation giving free access and effective drainage : g. r. girdlestone b m oxfd, f r c s. (0 replies)
  140. Arthritis: Etanercept for plaque psoriasis in children and adolescents (0 replies)
  141. Arthritis: 'old person's' arthritis afflicts thousands of kids (0 replies)
  142. Arthritis: New twist on prednisone for ra (0 replies)
  143. Arthritis: Sciatica (0 replies)
  144. Arthritis: Enbrel works for kids with psoriasis (0 replies)
  145. Arthritis: Genetic connection between short stature and arthritis uncovered (0 replies)
  146. Arthritis: Treatment of pregnant and non-pregnant rheumatic patients: a survey among dutch rheumatologists (0 replies)
  147. Arthritis: Methotrexate needed to curb anti-tnf-driven bone destruction in murine ra (0 replies)
  148. Arthritis: Lyme arthritis: diagnosis and management from a rheumatologist's perspective (0 replies)
  149. Arthritis: How an 'old person's disease' afflicts kids (0 replies)
  150. Arthritis: Long-term adalimumab improves quality of life in severe rheumatoid arthritis (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2009 Invision Power Services, Inc.